Home › Bids
› DoW Amyotrophic Lateral Sclerosis Research Program, Clinical
DoW Amyotrophic Lateral Sclerosis Research Program, Clinical Outcomes and Biomarkers Award
Estimated Value: $1,000,000
Open144 days leftHealthcaregrant
May 4, 2026
Sep 30, 2026 12:00 AM
Healthcare
grant
AI Summary
This is a funding opportunity (grant) from the Department of Defense for Amyotrophic Lateral Sclerosis (ALS) research, specifically focused on clinical outcomes and biomarkers. The award is part of the ALSRPCOBA program and is identified by funding opportunity number HT942526ALSRPCOBA.
Line Items
Item
Qty
Unit
Est. Unit Price
Est. Total
Category
Amyotrophic Lateral Sclerosis (ALS) Clinical Outcomes Research
1
project
$500,000.00
$500,000.00
Medical
Amyotrophic Lateral Sclerosis (ALS) Biomarkers Research
1
project
$500,000.00
$500,000.00
Medical
Estimated Bid Value
$1,000,000.00
Want the full details?
Sign up free to see the agency name, contact info, and the original bid posting link.